4Lau HT,Yu M,Fontana A,et al.Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice[].Science.1996
5Muruve DA,Nicolson AG,Manfro RC,et al.Adenovirus-mediated expression of Fas ligand induces hepatic appoptosis after systemic administration and appoptosis of ex vivo-infected pancreatic islet allografts and isografts[].Human Gene Therapy.1997
6Yamagami S,Kawashima H,Tsuru T,et al.Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants[].Transplantation.1997
2Boyle JJ,Bowyer DE,Weissberg PL,et al.Human blood-derived macrophage induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-Ligand/Fas interactions[J].Arterioscler Thromb Vasc Biol,2001,21(9):1 402-1 407.
3Elahi AW,Vijayakumar AN,Lichstein E,et al.Interplay of antibody and T cell response in acute myocardial infarction[J].J Lab Clin Med,2001,138(2):112-118.
4Ankersmit HJ,Weber T,Auer J,et al.Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina[J].Heart,2004,90(2):151-154.
5Setsuta K,Seino Y,Ogawa T,et al.Ongoing Myocardial Damage in Chronic Heart Failure is Related to Activated Tumor Necrosis Factorand Fas/Fas Ligand System[J].Circ J,2004,68(8):747-750.
6Nishigaki K,Minatoguchi S,Seishima M,et al.Plasma Fas Ligand,an inducer of apoptosis,and Plasma soluble Fas,an inhibitor of apoptosis,in patients with chronic congestive heart failure[J].J Am Coll cardiol,1997,29(6):1 214-1 220.
7Tsutamoto T,Wada A,Maeda K,et al.Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas:Plasma soluble Fas as a prognostic predictor in patients with congestive heart failure[J].J Card Fail,2001,7(4):322-328.
8Filippatos G,Leche C,Sunga R,et al.Expression of FAS adjacent to fibrotic foci in the failinghuman heart is not associated with increased apoptosis[J].Am J Physiol,1999,277(22):H445-H451.
9Bennett MR.Apoptosis in the cardiovascular system[J].Heart,2002,87(5):480-487.
10Daniel PT,Wieder T,Sturm I,et al.The kiss of death:Promises and failures of death receptors and ligands in cancer therapy[J].Leukemia,2001,15(7):1 022-1 032.
